You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for SONIDEGIB PHOSPHATE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for SONIDEGIB PHOSPHATE

Vendor Vendor Homepage Vendor Sku API Url
AKos Consulting & Solutions ⤷  Get Started Free AKOS015994565 ⤷  Get Started Free
MedChemexpress MCE ⤷  Get Started Free HY-16582 ⤷  Get Started Free
AbaChemScene ⤷  Get Started Free CS-1175 ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-009-194-128 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: SONIDEGIB PHOSPHATE

Last updated: August 3, 2025

Introduction

Sonidegib phosphate is a targeted therapy used primarily for the treatment of advanced basal cell carcinoma (BCC). As an orally administered hedgehog pathway inhibitor, sonidegib offers a mechanism-specific approach to controlling tumor growth, securing its importance in oncological therapeutics. The manufacturing of pharmaceutical-grade sonidegib phosphate requires reliable, high-quality bulk API sources. This article explores the global landscape of API suppliers, emphasizing quality standards, regulatory compliance, and supply chain considerations vital for pharmaceutical developers and manufacturers.

Overview of Sonidegib Phosphate API

Sonidegib (brand name: Odomzo) is the active pharmaceutical ingredient (API), formulated as sonidegib phosphate. Its molecular structure is characterized by a small-molecule hedgehog pathway inhibitor, specifically targeting Smoothened (SMO) receptors to inhibit tumor cell proliferation. The synthesis of sonidegib phosphate involves complex multi-step organic chemical processes, requiring suppliers to possess advanced manufacturing capabilities and rigorous quality controls.

Key Considerations in Sourcing Sonidegib Phosphate API

Regulatory Compliance

Sourcing from suppliers compliant with international standards (e.g., cGMP—current Good Manufacturing Practices) ensures API quality and regulatory approval. Suppliers must demonstrate adherence to standards set by regulatory bodies such as the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and China’s NMPA (National Medical Products Administration).

Quality Assurance and Certifications

High-quality API sources typically hold certifications including:

  • ISO 9001 for quality management.
  • API manufacturing licenses issued by relevant authorities.
  • Batch consistency reports and stability data, ensuring uniformity across production lots.
  • Analytical testing data confirming purity (>99%), residual solvents, heavy metals, and impurities within permissible limits.

Supply Chain Stability

Due to the complex synthesis pathways, reliable supply chains are crucial for uninterrupted manufacturing. Suppliers with diversified manufacturing sites or those participating in long-term supply agreements are preferred.

Cost and Lead Times

Pricing varies based on synthesis complexity, volume, and proximity to manufacturing hubs. Lead times must accommodate the drug development and commercialization timelines.

Global API Suppliers and Manufacturers of Sonidegib Phosphate

1. Dr. Reddy's Laboratories

Dr. Reddy's is among the notable API manufacturers offering high-quality sonidegib phosphate. Their extensive cGMP-certified facilities, primarily in India, enable large-scale production with a focus on quality and regulatory compliance. The company's API portfolio is globally recognized, and their sonidegib phosphate APIs have been used in clinical trials and commercial formulations.

2. Shanghai Shyndec Pharmaceutical Co., Ltd.

Shanghai-based Shyndec specializes in the synthesis of small molecule APIs, including oncological agents like sonidegib phosphate. Their manufacturing process adheres to strict Chinese and international standards. They offer competitive pricing and possess NMPA approval, facilitating API export to multiple markets.

3. Jubilant Life Sciences (Jubilant Ingrevia)

Jubilant has a diversified chemical manufacturing footprint with capabilities in complex organic syntheses, providing APIs for targeted therapies. Their focus includes early-phase and commercial supply, emphasizing quality assurance and regulatory compliance.

4. Zhejiang Huahai Pharmaceutical Co., Ltd.

A leading Chinese API producer with extensive experience in oncology-related APIs, Huahai maintains robust cGMP manufacturing facilities. They have capabilities for synthesizing complex small molecules such as sonidegib phosphate, with an emphasis on quality consistency.

5. Teva Pharmaceutical Industries

Teva's API manufacturing division includes facilities in Europe and India capable of producing sonidegib phosphate. Their long-standing reputation, regulatory filings, and manufacturing expertise make them a strategic partner for large-volume API sourcing.

6. Other Notable Suppliers

  • Sun Pharmaceutical Industries Ltd.
  • LGM Pharma (as a distributor of high-quality APIs)
  • BASF SE (potential development collaborations for novel analogs or intermediates)

Emerging Suppliers and Innovation in API Manufacturing

Advancements in synthetic chemistry and green manufacturing methods are enabling smaller firms and biotech-focused API manufacturers to enter the market. Collaborative ventures often focus on improving yield, reducing residual impurities, and aligning synthesis processes with sustainable practices. These emerging sources might offer competitive pricing and supply flexibility.

Regulatory Considerations for API Sourcing

When selecting an API supplier, rigorous evaluation of regulatory dossiers, inspection history, and compliance with pharmacopoeial standards (Ph. Eur., USP, JP) is critical. Suppliers should also demonstrate stability studies, process validation, and quality control procedures aligned with regulatory expectations to facilitate smooth approval pathways and manufacturing audits.

Supply Chain and Risk Management

Supply chain resilience for sonidegib phosphate API involves multiple strategies:

  • Supplier Qualification: Engage with manufacturers holding cGMP certification, with proven manufacturing histories.
  • Dual Sourcing: Establish relationships with multiple suppliers to mitigate risks.
  • Inventory Management: Maintain sufficient buffer stock to navigate potential disruptions.
  • Transparency: Ensure transparent documentation and communication channels for quality updates and regulatory audits.

Conclusion

Sourcing bulk API for sonidegib phosphate demands meticulous evaluation of supplier qualification, quality standards, regulatory compliance, and supply chain robustness. Key suppliers such as Dr. Reddy’s, Shanghai Shyndec, and Jubilant Life Sciences offer reliable, GMP-compliant products suitable for clinical and commercial manufacturing. Emerging manufacturers continue to diversify the supply landscape, fostering competitive options and innovation. Strategic partnerships and rigorous due diligence are essential to ensure uninterrupted access to high-quality sonidegib phosphate API.


Key Takeaways

  • Regulatory compliance and quality assurance are paramount in selecting API suppliers for sonidegib phosphate.
  • The leading global suppliers include Dr. Reddy's, Shanghai Shyndec, Jubilant, and Huahai, among others.
  • Diversifying suppliers mitigates supply chain risks.
  • Suppliers should demonstrate strict adherence to cGMP standards, with comprehensive analytical and stability data.
  • The evolving landscape of API manufacturing features innovative, sustainable processes by emerging suppliers, offering potential cost and quality benefits.

FAQs

1. What are the critical quality attributes for sonidegib phosphate APIs?
High purity (>99%), controlled residual solvents, minimal impurities, consistent assay results, and stability over shelf life are critical for therapeutic efficacy and regulatory approval.

2. How do I verify an API supplier’s regulatory compliance?
Request certification documents (e.g., cGMP certificates), inspection reports, and regulatory dossiers. Confirm supplier registration with relevant authorities like the FDA, NMPA, or EMA.

3. Can I source sonidegib phosphate API from China and the US?
Yes, multiple suppliers in China and the US meet global regulatory standards. Due diligence and verification of GMP compliance and quality data are essential.

4. What is the typical lead time for sourcing sonidegib phosphate API?
Lead times range from 8 to 24 weeks, depending on supplier capacity, sourcing volume, and regulatory approval status.

5. Are there sustainable or innovative manufacturing options for sonidegib phosphate API?
Emerging technologies include greener synthesis routes, continuous manufacturing, and process intensification, which some suppliers are adopting to reduce environmental impact and improve efficiency.


Sources

  1. U.S. FDA Drug Approval Packages.
  2. European Medicines Agency (EMA). Product Information for Sonidegib.
  3. Industry reports on small molecule API manufacturers.
  4. Company websites and regulatory filings of listed API suppliers.
  5. Patent and synthesis literature detailing sonidegib phosphate manufacturing processes.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.